Metraipolis › archive › dc_030bcc5fe6bf

Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative Study — Europe PMC PMID:28749622

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/28749622
DOI: 10.22034/apjcp.2017.18.7.1925
License (as archived): solo-consultazione
Archived: 2026-11-08T17:02:25.776Z
SHA-256 of the archived text: f8ffdaf8e9a0d7f20314f1f6b5acf79bfe278afd439907e9f8d25b59105115d3
Stable URL of this page: https://metraipolis.com/documento/dc_030bcc5fe6bf

How to cite

Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative Study — Europe PMC PMID:28749622 — Europe PMC (en), https://europepmc.org/article/MED/28749622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_030bcc5fe6bf (Metraipolis archive dc_030bcc5fe6bf, sha256 f8ffdaf8e9a0d7f20314f1f6b5acf79bfe278afd439907e9f8d25b59105115d3)

BibTeX

@misc{dc030bcc5fe6bf,
  title = {Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative Study — Europe PMC PMID:28749622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28749622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_030bcc5fe6bf; sha256 f8ffdaf8e9a0d7f20314f1f6b5acf79bfe278afd439907e9f8d25b59105115d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28749622. Agents can read the archived copy with the MCP tool read_document.